Institutional Ownership
Carisma Therapeutics Inc
CUSIP 14216R101COMCARMQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Sep 2, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Sep 2, 2025 | Healthcap Vii, L.P. | 13D/A | — | — | SEC |
| 2 | Aug 29, 2025 | Healthcap Vii, L.P. | 13D/A | 4.8% | — | SEC |
| 3 | Aug 21, 2025 | Healthcap Vii, L.P. | 13D/A | 6.5% | — | SEC |
| 4 | Apr 25, 2025 | Abbvie Biotechnology Ltd. | 13G/A | 11.0% | 1.86M | SEC |
| 5 | May 28, 2024 | Healthcap Vii, L.P. | 13D/A | 8.2% | 3.40M | SEC |
| 6 | Mar 13, 2024 | Abbvie Biotechnology Ltd | 13G | 6.8% | 2.75M | SEC |
| 7 | Mar 7, 2024 | Healthcap Vii, L.P. | 13D/A | 8.4% | 3.40M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 3.9% | 1.57M | SEC |
| 9 | Feb 2, 2024 | Longview Innovation Corp. | 13G/A | 6.7% | 2.71M | SEC |
| 10 | Jan 26, 2024 | Trustees Of The University Of Pennsylvania | 13D/A | 3.1% | 1.25M | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Carisma Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Merck & Co., Inc. | 1.47M | $47.9K |
| 2 | Union Bancaire Privee, Ubp SA | 785 | $22 |
| 3 | Ascentis Independent Advisors | 200 | $6 |